Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes

R. Cohen; C. W. le Roux; D. Papamargaritis; J. E. Salles; T. Petry; J. L. Correa; D. J. Pournaras; M. Galvao Neto; B. Martins; P. Sakai; C. A. Schiavon; C. Sorli Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes Diabetic Medicine
Insulin Resistance & Diabetes

Another look at the (endoscopic duodenal liner) ENDO trial, or how to avoid the burial of a valuable antidiabetic tool

R. Cohen; M. P. Galvão Neto; C. L. Roux Another look at the (endoscopic duodenal liner) ENDO trial, or how to avoid the burial of a valuable antidiabetic tool Surg Obes Relat Dis
Insulin Resistance & Diabetes

The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes-Reply

R. V. Cohen; T. V. Pereira; C. W. le Roux The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes-Reply JAMA Surg
Chronic Kidney Disease Insulin Resistance & Diabetes

Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial

R. V. Cohen; T. V. Pereira; C. M. Aboud; P. P. Caravatto; T. B. Petry; J. L. Correa; C. A. Schiavon; M. Correa; C. E. Pompílio; F. N. Pechy; C. W. le Roux Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial BMJ Open
Insulin Resistance & Diabetes

Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial

R. V. Cohen; T. V. Pereira; C. M. Aboud; T. B. Z. Petry; J. L. Lopes Correa; C. A. Schiavon; C. E. Pompílio; F. N. Q. Pechy; A. C. C. da Costa Silva; F. L. G. de Melo; L. P. Cunha da Silveira; P. P. de Paris Caravatto; H. Halpern; F. L. J. Monteiro; B. da Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial JAMA Surg
Chronic Kidney Disease Insulin Resistance & Diabetes

Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery

L. L. Chuah; A. D. Miras; D. Papamargaritis; S. N. Jackson; T. Olbers; C. W. le Roux Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery Surg Obes Relat Dis
Insulin Resistance & Diabetes

Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device

J. Casella-Mariolo; L. Castagneto-Gissey; G. Angelini; A. Zoli; P. Marini; S. R. Bornstein; D. J. Pournaras; F. Rubino; C. W. le Roux; G. Mingrone; G. Casella Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device EBioMedicine
Insulin Resistance & Diabetes NAFLD

Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery

A. L. Canney; R. V. Cohen; J. A. Elliott; M. A. C; W. P. Martin; N. G. Docherty; C. W. le Roux Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery Diab Vasc Dis Res
Insulin Resistance & Diabetes

Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery

T. G. Braga; M. D. Graças Coelho de Souza; M. Menezes; J. F. Nogueira Neto; L. Dellatorre-Teixeira; E. Bouskela; C. W. le Roux; L. G. Kraemer-Aguiar Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery Surg Obes Relat Dis
Gut-Brain Insulin Resistance & Diabetes

Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present

C. Brosnan; J. C. Bolger; E. M. Bolger; M. E. Kelly; R. Tully; M. AlAzzawi; W. B. Robb Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present Obes Surg
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page46 Page47 Page48 … Page53 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI